RE:RE:Moving at paceImho its a combination of factors 1) sector is down across the board but its slowly turning up 2) DOC said its Q3 was a transitional qtr....it still disappointed folks and Q4 is a long time to wait to see how the year ends up with the extra month that Venture Stocks get to report. Ie end April vs end of March. 3) DOC is high retail stock holding and there is a lot of disinformation being played by traders ie the dilutions and acquisitions are positioned as negative and folks easily believe shorts/bashers opposed to getting better educated on the Company and those surrounding it etc.
So to answer your question: I think the market is waiting for reports/filings as a next catalyst....good news is, Q4 is end of this month and Q1 I'd end of May.
5 covering analysts of DOC: 1 has strong buy and the other 4 have buy ratings. Avg TP is $3.82 with Laurentian projecting $4.25 and Cannacord having the lowest of $3.50/share.....after today and with earnings ahead, this all should move upward.......